CRISPR/Cas9 nickase-mediated inactivation of hepatitis B virus replication

被引：0
|
作者：
Karimova, M. [1 ]
Beschorner, N. [1 ]
Dammermann, W. [2 ]
Chemnitz, J. [1 ]
Indenbirken, D. [1 ]
Grundhoff, A. [1 ,3 ]
Lueth, S. [2 ]
Buchholz, F. [4 ,5 ]
zur Wiesch, J. Schulze [6 ]
Hauber, J. [1 ]
机构：
[1] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf 1, Inst Expt Immunol & Hepatol, Dept Med, Hamburg, Germany
[3] German Ctr Infect Res DZIF, Hamburg, Germany
[4] Univ Hosp, Dept Med Syst Biol, Dresden, Germany
[5] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany
[6] Univ Med Ctr Hamburg Eppendorf 1, Dept Med, Hamburg, Germany
来源：
JOURNAL OF VIRAL HEPATITIS | 2015年 / 22卷
关键词：
D O I：
10.1111/jvh.23_12425
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P025
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [31] Abrogation of Marek's disease virus replication using CRISPR/Cas9
    Hagag, Ibrahim T.
    Wight, Darren J.
    Bartsch, Denise
    Sid, Hicham
    Jordan, Ingo
    Bertzbach, Luca D.
    Schusser, Benjamin
    Kaufer, Benedikt B.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [32] Abrogation of Marek’s disease virus replication using CRISPR/Cas9
    Ibrahim T. Hagag
    Darren J. Wight
    Denise Bartsch
    Hicham Sid
    Ingo Jordan
    Luca D. Bertzbach
    Benjamin Schusser
    Benedikt B. Kaufer
    Scientific Reports, 10
  • [33] Inactivation of Cancer Mutations Utilizing CRISPR/Cas9
    Gebler, Christina
    Lohoff, Tim
    Paszkowski-Rogacz, Maciej
    Mircetic, Jovan
    Chakraborty, Debojyoti
    Camgoz, Aylin
    Hamann, Martin V.
    Theis, Mirko
    Thiede, Christian
    Buchholz, Frank
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01):
  • [34] Target-dependent nickase activities of the CRISPR–Cas nucleases Cpf1 and Cas9
    Becky Xu Hua Fu
    Justin D. Smith
    Ryan T. Fuchs
    Megumu Mabuchi
    Jennifer Curcuru
    G. Brett Robb
    Andrew Z. Fire
    Nature Microbiology, 2019, 4 : 888 - 897
  • [35] Enhanced delivery of CRISPR/Cas9 system based on biomimetic nanoparticles for hepatitis B virus therapy
    Wu, Kexin
    He, Miao
    Mao, Binli
    Xing, Yangchen
    Wei, Shiqi
    Jiang, Dongjun
    Wang, Shunyao
    Alkuhali, Asma A.
    Guo, Jinjun
    Gan, Zongjie
    Li, Man
    Li, Xiaosong
    Chen, Huali
    JOURNAL OF CONTROLLED RELEASE, 2024, 374 : 293 - 311
  • [36] THE CRISPR/Cas9 SYSTEM BEING AS A CUTTER FOR COVALENTLY CLOSED CIRCULAR DNA OF HEPATITIS B VIRUS
    Pan, X. -B.
    Zhao, X. -L.
    Wei, L.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S521 - S521
  • [37] Efficient Generation of hiPSC Neural Lineage Specific Knockin Reporters Using the CRISPR/Cas9 and Cas9 Double Nickase System
    Li, Shenglan
    Xue, Haipeng
    Long, Bo
    Sun, Li
    Tai Truong
    Liu, Ying
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2015, (99):
  • [38] INHIBITIONS OF HEPATITIS C VIRUS REPLICATION WITH THE HELP OF CRISPR/CAS 9 TECHNOLOGY
    Farooq, Muhammad Umar
    Mehwish
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (05): : 9578 - 9584
  • [39] The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication
    Wang, Jie
    Chen, Ran
    Zhang, Ruiyang
    Ding, Shanlong
    Zhang, Tianying
    Yuan, Quan
    Guan, Guiwen
    Chen, Xiangmei
    Zhang, Ting
    Zhuang, Hui
    Nunes, Frederick
    Block, Timothy
    Liu, Shuang
    Duan, Zhongping
    Xia, Ningshao
    Xu, Zhongwei
    Lu, Fengmin
    THERANOSTICS, 2017, 7 (12): : 3090 - 3105
  • [40] CRISPR/Cas9
    杨丽
    中南医学科学杂志, 2016, 44 (05) : 585 - 585
12345